S
Shin-ichi Momomura
Researcher at Jichi Medical University
Publications - 360
Citations - 7399
Shin-ichi Momomura is an academic researcher from Jichi Medical University. The author has contributed to research in topics: Heart failure & Percutaneous coronary intervention. The author has an hindex of 34, co-authored 342 publications receiving 5689 citations.
Papers
More filters
Journal ArticleDOI
Rivaroxaban vs. warfarin in Japanese patients with atrial fibrillation – the J-ROCKET AF study –.
Masatsugu Hori,Masayasu Matsumoto,Norio Tanahashi,Shin-ichi Momomura,Shinichiro Uchiyama,Shinya Goto,Tohru Izumi,Yukihiro Koretsune,Mariko Kajikawa,Masaharu Kato,Hitoshi Ueda,Kazuya Iwamoto,Masahiro Tajiri +12 more
TL;DR: J-ROCKET AF demonstrated the safety of a Japan-specific rivaroxaban dose and supports bridging the global ROCKET AF results into Japanese clinical practice.
Journal ArticleDOI
JCS 2017/JHFS 2017 Guideline on Diagnosis and Treatment of Acute and Chronic Heart Failure ― Digest Version ―
Hiroyuki Tsutsui,Mitsuaki Isobe,Hiroshi Ito,Ken Okumura,Minoru Ono,Masafumi Kitakaze,Koichiro Kinugawa,Yasuki Kihara,Yoichi Goto,Issei Komuro,Yoshikatsu Saiki,Yoshihiko Saito,Yasushi Sakata,Naoki Sato,Yoshiki Sawa,Akira Shiose,Wataru Shimizu,Hiroaki Shimokawa,Yoshihiko Seino,Koichi Node,Taiki Higo,Atsushi Hirayama,Miyuki Makaya,Tohru Masuyama,Toyoaki Murohara,Shin-ichi Momomura,Masafumi Yano,Kenji Yamazaki,Kazuhiro Yamamoto,Tsutomu Yoshikawa,Michihiro Yoshimura,Masatoshi Akiyama,Toshihisa Anzai,Shiro Ishihara,Takayuki Inomata,Teruhiko Imamura,Yu-ki Iwasaki,Tomohito Ohtani,Katsuya Onishi,Takatoshi Kasai,Mahoto Kato,Makoto Kawai,Yoshiharu Kinugasa,Shintaro Kinugawa,Toru Kuratani,Shigeki Kobayashi,Yasuhiko Sakata,Atsushi Tanaka,Koichi Toda,Takashi Noda,Kotaro Nochioka,Masaru Hatano,Takayuki Hidaka,Takeo Fujino,Shigeru Makita,Osamu Yamaguchi,Uichi Ikeda,Takeshi Kimura,Shun Kohsaka,Masami Kosuge,Masakazu Yamagishi,Akira Yamashina +61 more
TL;DR: This English language document is a revised digest version of Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure (JCS 2017/JHFS 2017) reported at the Japanese Circulation Society Joint Working Groups performed in 2017.
Journal ArticleDOI
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure
John R. Teerlink,Rafael Diaz,G. Michael Felker,John J.V. McMurray,Marco Metra,Scott D. Solomon,Kirkwood F. Adams,Inder S. Anand,Alexandra Arias-Mendoza,Tor Biering-Sørensen,Michael Böhm,Diana Bonderman,John G.F. Cleland,John G.F. Cleland,Ramón Corbalán,María G. Crespo-Leiro,Ulf Dahlström,Luis E. Echeverría,James C. Fang,Gerasimos Filippatos,Cândida Fonseca,Eva Goncalvesova,Assen Goudev,Jonathan G. Howlett,David E. Lanfear,Jing Li,M. Lund,Peter S. Macdonald,Viacheslav Mareev,Shin-ichi Momomura,Eileen O'Meara,Alexander Parkhomenko,Piotr Ponikowski,Felix José Alvarez Ramires,Pranas Šerpytis,Karen Sliwa,Jindrich Spinar,Thomas M. Suter,János Tomcsányi,Hans Vandekerckhove,Dragos Vinereanu,Adriaan A. Voors,Mehmet Yilmaz,Faiez Zannad,Lucie Sharpsten,Jason C. Legg,Claire Varin,Narimon Honarpour,Siddique Abbasi,Fady I. Malik,Christopher E. Kurtz +50 more
TL;DR: Among patients with heart failure and a reduced ejection, patients who received omecamtiv mecarbil had a lower incidence of a composite of a heart-failure event or death from cardiovascular causes than those who received placebo.
Journal ArticleDOI
Prognosis of Patients With Heart Failure and Obstructive Sleep Apnea Treated With Continuous Positive Airway Pressure
Takatoshi Kasai,Koji Narui,Tomotaka Dohi,Naotake Yanagisawa,Sugao Ishiwata,Minoru Ohno,Tetsu Yamaguchi,Shin-ichi Momomura +7 more
TL;DR: Therapy with CPAP significantly reduced the risk of death and hospitalization among patients with HF and OSA, however, reduced compliance withCPAP therapy was significantly associated with an increased risk ofDeath andospitalization.
Journal ArticleDOI
Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association.
Yusuke Takagi,Satoshi Yasuda,Jun Takahashi,Ryusuke Tsunoda,Yasuhiro Ogata,Atsushi Seki,Tetsuya Sumiyoshi,Motoyuki Matsui,Toshikazu Goto,Yasuhiko Tanabe,Shozo Sueda,Toshiaki Sato,Satoshi Ogawa,Norifumi Kubo,Shin-ichi Momomura,Hisao Ogawa,Hiroaki Shimokawa +16 more
TL;DR: The spasm provocation tests have an acceptable level of safety and the evaluation of spasm type may provide useful information for the risk prediction of VSA patients.